Sarah Teichmann receives EMBO Gold Award
The European Molecular Biology Organisation (EMBO) Gold Award 2015 has been awarded to Sarah Teichmann, Senior Group Leader at the Wellcome Trust Sanger Institute and Research Group Leader at the European Bioinformatics Institute (EMBL-EBI), in recognition of her contribution to science. The award underscores the increasing importance of informatics and interdisciplinary research in biology.
Dr Teichmann received the Gold Medal ‘for her use of computational and experimental methods to better understand genomes, proteomes and evolution’. EMBO recognised in particular her research into the regulation of gene expression and the nature of protein complexes, the evolutionary conservation of assembly pathways of protein complexes, and predicting these pathways based on three-dimensional protein structures.
“Sarah’s expertise in bioinformatics seems infinitely adaptable and is coupled with skills for directing exquisitely controlled laboratory-based experiments. Such broad-spectrum abilities are rare.”
EMBO Member Professor Veronica van Heyningen
“Informatics has always been at the heart of my research Using statistics and computer science to tease out meaning from the ‘wet-lab’ experiments we carry out. Informatics has become an essential component of biology, as genomics and imaging become more and more prevalent. It offers countless opportunities and challenges as new technologies such as single-cell sequencing come to the fore, demanding new methods from computer science, maths and physics.”
Dr Sarah Teichmann, co-founder of the Sanger Institute–EMBL-EBI Single Cell Genomics Centre
Teichmann will receive her medal with fellow awardee Dr Ido Amit on 5 September 2015 at the opening session of The EMBO Meeting in Birmingham.
More information
About Sarah Teichmann
Dr Sarah Teichmann graduated from Trinity College, Cambridge in 1996 with a degree in Natural Sciences (Biochemistry). She then joined Dr Cyrus Chothia’s group at the MRC Laboratory of Molecular Biology to study computational genomics. Her PhD thesis explored protein families and the domain organisation of proteins in the first completely sequenced genomes. In 2001, Dr Teichmann started a research group at the MRC Laboratory of Molecular Biology. In 2013, she moved to the Wellcome Genome Campus in Hinxton, near Cambridge, where she holds a joint appointment at the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute.
Selected websites
European Bioinformatics Institute
The European Bioinformatics Institute is part of EMBL, and is a global leader in the storage, analysis and dissemination of large biological datasets. EMBL-EBI helps scientists realise the potential of ‘big data’ in biology by enhancing their ability to exploit complex information to make discoveries that benefit mankind. We are a non-profit, intergovernmental organisation funded by EMBL’s 21 member states and two associate member states. Our 570 staff hail from 57 countries, and we welcome a regular stream of visiting scientists throughout the year. We are located on the Wellcome Genome Campus in Hinxton, Cambridge in the United Kingdom.
The Wellcome Genome Campus
The Wellcome Genome Campus is home to some of the world’s most advanced institutes working at the interface of genomics and computational biology. The campus brings together a diverse and exceptional scientific community in a culture and environment that fosters creativity and rewards bold, ambitious thinking. They are committed to delivering life-changing science with the reach, scale and imagination to deliver solutions to some of humanity’s greatest challenges.
The Wellcome Trust Sanger Institute
The Wellcome Trust Sanger Institute is one of the world’s leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease.
The Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
